Press Releases

Press Releases

June 2, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2023
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
May 8, 2023
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
May 5, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 25, 2023
ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference
April 18, 2023
ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 16, 2023
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
March 14, 2023
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 6, 2023
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 3, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Displaying 1 - 10 of 13